Pain, a Non-Motor Sign Associated with Parkinson’s Disease: The Experience of the Institute of Neurology of Simbaya, Conakry  

作　　者：Namory Camara Mohamed Tafsir Diallo Karinka Diawara Mohamed Lamine Touré Bi Joel Cyrille Zamblé Fodé Abass Cissé Namory Camara;Mohamed Tafsir Diallo;Karinka Diawara;Mohamed Lamine Touré;Bi Joel Cyrille Zamblé;Fodé Abass Cissé(Simbaya Neurology Institute, Conakry, Guinea;Department of Neurology of The Ignace Deen University Hospital, Conakry, Guinea)

机构地区：[1]Simbaya Neurology Institute, Conakry, Guinea [2]Department of Neurology of The Ignace Deen University Hospital, Conakry, Guinea

出　　处：《Advances in Parkinson's Disease》2025年第1期1-11,共11页帕金森(英文)

摘　　要：Introduction: Pain has been defined for more than 20 years by the International Association for the Study of Pain (IASP) as an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. It has been recognized as a feature of Parkinson’s disease (PD) since the first descriptions of the disease. Material and Methods: This was a prospective descriptive study lasting six (06) months from November 1, 2023 to April 30, 2024. We included all patients diagnosed with PD and who had pain. Sociodemographic, clinical, paraclinical and therapeutic data were evaluated for each patient. Results: We identified a sample of 62 Parkinson’s patients, of whom 52 patients or 85.2% had associated pain. We noted a male predominance (38M/14F) and a sex ratio of 2.71. Musculoskeletal pain was common in 80% of our respondents. WHO level I, antidepressants and background treatment for KD were the most prescribed molecules. Conclusion: Our study shows a frequency of pain in PD. However, musculoskeletal pain is the most frequently encountered type of pain in PD patients. WHO step I analgesics, antidepressants and background treatment of KD were the main prescriptions in our study.Introduction: Pain has been defined for more than 20 years by the International Association for the Study of Pain (IASP) as an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. It has been recognized as a feature of Parkinson’s disease (PD) since the first descriptions of the disease. Material and Methods: This was a prospective descriptive study lasting six (06) months from November 1, 2023 to April 30, 2024. We included all patients diagnosed with PD and who had pain. Sociodemographic, clinical, paraclinical and therapeutic data were evaluated for each patient. Results: We identified a sample of 62 Parkinson’s patients, of whom 52 patients or 85.2% had associated pain. We noted a male predominance (38M/14F) and a sex ratio of 2.71. Musculoskeletal pain was common in 80% of our respondents. WHO level I, antidepressants and background treatment for KD were the most prescribed molecules. Conclusion: Our study shows a frequency of pain in PD. However, musculoskeletal pain is the most frequently encountered type of pain in PD patients. WHO step I analgesics, antidepressants and background treatment of KD were the main prescriptions in our study.

关 键 词：PAIN Parkinson’s Disease Conakry 

分 类 号：R74[医药卫生—神经病学与精神病学]